← Evidence map

TrialClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).

N Kentepozidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2017
2018
2019
2020
2021
2022
2023
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 27492015